1. Антонов Н.С., Стулова О.Ю., Зайцева О.Ю. Эпидемиология, факторы риска, профилактика // Хроническая обструктивная болезнь легких/ Под ред. А.Г. Чучалина. М, 1998; 66–82.

2. Бабак С.Л., Григорьянц Р.А., Чучалин А.Г. Нарушения дыхания во время сна у пациентов ХОБЛ //Хроническая обструктивная болезнь легких. Под ред. А.Г. Чучалина. М, 1998; 216–34.

3. Влияние окружающей среды на здоровье человека. Женева, ВОЗ, 1974; 215.

4. Овчинников А.А.; Эндоскопическая диагностика и терапия хронического обструктивного бронхита //Хроническая обструктивная болезнь легких. Под ред. А.Г. Чучалина. М, 1998; 423–36.

5. Сенкевич Н.Ю. Качество жизни при хронической обструктивной болезни легких // Хроническая обструктивная болезнь легких. Под ред. А.Г. Чучалина. М, 1998; 437.

6. Федорова Т.А. Хроническое легочное сердце // Хроническая обструктивная болезнь легких. Под ред. А.Г. Чучалина. М, 1998; 192–216.

7. Хроническая обструктивная болезнь легких. Под ред А.Г. Чучалина. М, 1998.

8. Черняев А.Л, Самсонова М.В. Патологическая анатомия хронических обструктивных заболевании легких //Хроническая обструктивная болезнь легких. Под ред. А.Г Чучалина. М, 1998; 366–401.

9. Чучалин А.Г. Хронические обструктивные болезни легких//Хроническая обструктивная болезнь легких. Под ред. А.Г. Чучалина. М, 1998; 11–26.

10. Чучалин А.Г., Айсанов З.Р. Роль дыхательной мускулатуры в патогенезе обструктивных заболевании легких и пути терапевтическои коррекции // Пробл. туб., 1987; 7: 65–9.

11. Чучалин А.Г., Айсанов З.Р. Нарушение функции дыхательных мышц при хронических обструктивных заболеваниях легких//Тер. арх., 1988; 8: 126–32.

12. Чучалин А.Г., Сахарова Г.М. Болезни легких курящего человека//Хроническая обструктивная болезнь легких / Под ред. А.Г. Чучалина. М, 1998; 338.

13. Чучалин А.Г., Айсанов З.Р., Калманова Е.Н. Функциональный диагноз у больных хронической обструктивной болезнью легких// Хроническая обструктивная болезнь легких/ Под ред. А.Г. Чучалина. М, 1998; 130–45.

14. Шварц Г.Я., Цой А.Н. Антихолинергические средства в лечении больных хронической обструктивной болезнью легких//Хроническая обструктивная болезнь легких/Под ред. А.Г. Чучалина. М, 1998; 234–49.

15. Шмелев Е.И. Хронический обструктивныи бронхит // Хроническая обструктивная болезнь легких / Под ред. А.Г. Чучалина. М, 1998; 402.

16. American Thoracic Society Guidelines for pulmonary rehabilitation //Amer Rev Resp Dis, 1981; 124: 663–6.

17. Anderson H., Esmail A., Hollowell J., et al. Epidemiologically based needs assessment i: lower respiratory disease. London, 1994.

18. Barnes P.J., Bronchodilators: basic pharmacology//Chronic obstructive pulmonary disease. London, 1995; 391–417.

19. Barnes P.J., Buist A.S. The role of anticholinergics in chronic obstructive pulmonary disease and bronchial asthma. 1997.

20. Boyd G., Monce A., Pounsford J., et al. An evaluation of salmeterol in the treatment of chronic obstructive pumonary disease//Eur Respir J., 1997; 10 (4): 815–21.

21. Bradley Т.D., Rutherford R., Lue F. Role of diffuse airway obstruction in the hypercapnia of obstructive sleep apnea // Amer Rev Resp Dis, 1986; 134: 920–4.

22. Brand P., Quanjer P.Н., Postma D.S. et al. and the Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Interpretation of bronchodilator response in patients with obstructive airways disease // Thorax, 1992; 47: 429–36.

23. BTS guidelines for the management of chronic obstructive pulmonary disease// Ibid, 1997; 5: 1–28.

24. Buist A.S. Risk factors for COPD//Eur Respir Rev, 1996; 6 (39): 253–8.

25. Burge P.S. Occupation and chronic obstructive pulmonary disease (COPD) // Eur Respir J, 1994; 7: 1032–34.

26. Calverley, Georgopoulos D. Chronic obstructive pulmonary disease symptoms and signs // Management of chronic obstructive pulmonary disease / Eds: Postma D.S., Siafakas N.M. The European Respiratory Society Monograph, 7 May, 1998; 6–25.

27. Canadian Thoracic Society Workshop Group Guidelines for the assessment and management of chronic obstructive pulmonary disease // Can med Ass J, 1992; 147: 420–8.

28. Ciba Guest Symposium Terminology, definitions and classification of chronic pulmonary emphysema and related conditions//Thorax, 1959; 14: 286–99.

29. Cooper С.В., Waterhouse J., Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long-term domiciliaryoxygen therapy// Ibid. 1987; 42: 105–10.

30 EvansW.W. Plasma theophylline concentrations, six minute walking distances and breathlessness in patients with chronic airflow obstruction // BMJ,1984; 289: 1649–51.

31 Fletcher С.M., Peto R., Tinker С.M., Speizer F.E. The natural history of chronic bronchitis and emphysema. Oxford, 1976.

32 Folgenng H., DeKhuijzen R., Cox N., Van Herwaarden С. The rationale of pulmonare rehabilitation // Eur Respir Rev., 1991; 6: 464–71.

33. Friedman M. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease // Amer J Med., 1996; 100 (1): 30–39.

34. Garyard P., Orehek J., Grimaud С., Charpin С. Bronchoconstrictor effects of deep inspiration in patients with asthma //Amer Rev Respir Dis., 1975; 111: 433–9.

35. Gelb A.F., Schein M., Kuei J., et al. Limited contribution of emphysema in advanced chronic obstructive pulmonary disease//Ibid, 1993; 147 (5): 1157–61.

36. Georgopoulos D., Anthonisen N. Symptoms and signs of COPD //Chronic obstructive pulmonary disease/Eds N.S. Cherniak - Philadelphia, 1991; 357–63.

37. Gibson G.J., MacNee W. Chronic obstructive pulmonary disease investigations and assessment of severity // Management of chronic obstructive pulmonary disease / Eds: D.S. Postma, N M Siafakas -The European Respiratory Society Monograph -7, May, 1998; 25–41.

38. Global initiative for asthma Global strategy for asthma management and Prevention NHLBI/WHO Workshop report. 1993 (NIH Publication 95-3659, January 1995) - Bethesda, 1995 -1-176.

39. Goldstein R.S., Gort E.H., Stubbing D., et al. Randomised controlled trial of respiratory rehabilitation // Lancet, 1994; 344: 1394–7.

40. Halliwell В., Guttendge J.M. Free radicals in biology and medicine. Oxford, 1989; 58 (188): 366–494.

41. Hoidal J.R., Jeffery P.К. Cellular and biochemical mechanisms in chronic obstructive pulmonary disease // Im Management of chronic obstructive pulmonary disease /Eds: Postma D.S., Siafakas N.M. The European Respiratory Society Monograph, 7 May, 1998; 1–302.

42. Jarvis M.J. Smoking cessation // Eur Respir Rev.,1997; 7 (45): 230–4.

43. Juniper E.F., Guyatt G.H., Feme P.J, Griffith L.E. Measuring the quality of life in asthma // Amer Rev Respir Dis., 1993; 147: 832–8.

44. Kerrebijn К.F. Similarities and discrepancies between asthma and chronic pulmonary disease //Ibid, 1991; 143: 1149–96, 1419–71.

45. Kohama A., Tanouchi J., Masatsugu H., Kitabatake A., Kamada Т. Pathologic involvement of the left ventricle in chronic cor pulmonale // Chest, 1990; 98: 794–800..

46. Lehtonen J., Sutinen S., Ikaheimo M., Paakko P. Electrocardiographic criteria for the diagnosis of right ventricular hypertrophy verified at autopsy // Ibid, 1988; 93: 839–42.

47. Levin D., Little К., Laughlin К. Addition of anticholinergic solution prolongs bronchodilator effect of beta-2-agonists in patients with chronic obstructive pulmonary disease // Amer J Med., 1996; 100 (1): 40–8.

48. McKay S.E., Howie С.А., Thomson A.H., et al. Value of theophylline treatment in patients handicapped by chronic obstructive pulmonary disease//Thorax, 1993; 48: 27–32.

49. Medical Research Council. Definition and classification of chronic bronchitis for clinical and epidemiological purposes// Lancet, 1965; 1: 775–9.

50. Morgan M.D.L., Denison D.M., Strickland В. Value of computed tomography for selecting patients with bullous emphysema // Thorax, 1986; 41: 855–62.

51 Morrell N.W., Wignall В.К., Biggs Т., Seed W.A. Collateral ventilation and gas exchange in emphysema // Amer J Respir Crit Care Med, 1994; 150 (3): 635–41.

52. Mullen J.BM., Wnght J.L., Wiggs B.R., et al. Reassessment of inflammation of airway in chronic bronchitis// BMJ, 1985; 291: 1235-–9.

53. Mulloy E., McNicholas W.T. Theophylline improves gas exchange during rest, exercise and sleep in severe chronic obstructive pulmonary disease//Amer Rev Respir Dis., 1993; 148: 1030–6.

54. Murciano D., AuclairM-H., Panente R., Aubier M. A. randomised controlled trial oftheophylline in patients with severe chronic obstructive pulmonary disease//New Engl J Med., 1989; 320: 1521–5.

55. Murphy Т.F., Sethi S. State of the art Bacterial infection on chronic obstructive pulmonary disease //Amer Rev Respir Dis., 1992; 146: 1067–83.

56. Nagai A., West W.W, Paul J.L, Thurlbeck W.M, The national institutes of health intermittent positive-pressure breathing trial Pathology studies II Correlations between morphologic findings, clinical findings and evidence of expiratory air-flow obstruction // did, 1985; 132: 946–52.

57. Ollerenshaw S.L., Woolcock A.J. Characteristics inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow lim. // Ibid., 1992; 145: 922–7.

58. Pare P.D., Bai Т.R. Airway wall remodelling in chronic obstructive disease // Eur Respir Rev., 1966; 6 (39): 259–63.

59. Pitcher W.D. Cunnmgham H.S. Oxygen cost of increasing tidal volume and diaphragm flattening in obstructive pulmonary disease//J appl Physiol., 1993; 74 (6): 2750–6.

60. Postma D.S. Epidemiology of COPD risk factors // COPD: Diagnosis and treatment. Excerpta Medica, 1996, 17 Report. Chronic bronchitis in Great Britain. BMJ, 1961; 12–973.

61. Pride N.В., Macklem P.T. Lung mechanics in disease // Handbook of Physiology III The Respiratory System Mechanics of Breathing-Bethesda, 1986; 659–92.

62. Pride N.В.,Vermeire P. Definition and differential diagnosis// Management of chronic obstructive pulmonary disease / Eds: Postma D.S., Siafakas N.M. The European Respiratory Society Monograph, 7 May, 1998; 2–6.

63. Rennard S.I, Romberger D.J., Spurzem J.R. Mechanisms of airflow obstruction: role of cells and mediators// Monaldi Arch Chest Dis, 1993; 48 (5): 407–10.

64. Rennard S.L., Serby С.W., Ghafoun M., et al. Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials//Chest, 1996; 110 (1): 62–70.

65. Repine J.E., Bast A., Lankhorst L. Oxidative stress in chronic obstructive pulmonary disease//Amer J Respir Crit Care Med, 1997; 156: 341–57.

66. Rijcken В., Britton J. Epidemiology of chronic obstructive pulmonary disease // Management ot chronic obstructive pulmonary disease / Eds: Postma D.S., Siafakas N.M. The European Respiratory Society Monograph, 7 May, 1998; 1–302.

67. Roberts C.M., Bugler J.R., Melchor R., et al. Value of pulse oximetry for long-term oxygen therapy requirement//Eur Respir J, 1993; 6: 559–62.

68. Rodriguez-Roisin R., MacNee W. Pathophysiology of chronic obstructive pulmonary disease//Management of chronic obstructive pulmonary disease / Eds: Postma D.S., Siafakas N.M. The European Respiratory Society Monograph, 7 May, 1998; 107–127.

69. Roffel A.F. Meurs H., Zaagsma J. Muscarinic receptors and the lung. Relevance chronic obstructive pulmonary disease and asthma // The role of anticholinergics in chronic obstructive pulmonary disease and chronic asthma / Eds: Barnes P.J., BuistA.S., 1997; 92–125.

70. Samelchuk E.L., Chuchalin A.G. Mis-sense mutation of a1-antichymotrypsin and COPD // Lancet, 1993; 342–624.

71. Sandford A.J., Weir Т.D., Pare P. Genetic risk factors for chronic obstructive pulmonary disease // Eur Respir J, 1997; 10: 1380–91.

72. Shapiro S.D. The pathogenesis of emphysema the elastase- antielastase hypothesis 30 years later // Proceedings of Assoc Amer Phys., 1995; 107: 346–52.

73. Siafakas N.M., Vermeire P., Pride N.В. et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). A consensus statement of the European Respiratory Soiety (ERS) // Eur Respir J, 1995; 8: 1398–1420.

74. Snider G.L., Klenennan J., Thunbeck W.M., Benga. The definition of emphysema Report of a national and blood institute, division of lung disease.//Amer Rev Respir Dis, 1985; 132: 182–5.

75. Standardization of lung function tests. Report Working Party European Community for Steel and Coal. Official Statement of the European Respiratory Society // Eur Respir J, 1993; 6 (16): 1–121.

76. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease ATS statement // Amer J Respir Crit Care Med, 1995; 152: 77–120.

77. Stanescu D. Small airways disease and chronic obstructive pulmonary disease // Management of chronic obstructive pulmonary disease / Eds: Postma D.S., Siafakas N.M. The European Respiratory Society Monograph, 7 May, 1998; 107–27.

78. Thurlbeck W.M., Simon G. Radiographic appearance of the chest in emphysema // Amer J Roentgenol, 1978; 130: 429–40.

79. Thurlbeck W.M. Chronic airflow obstruction // Pathology of Lung / Eds by W M Thurlbeck, A M Chung, 2-nd Ed -Stuttgart, N.Y., 1995; 739–825.

80. Timens W., Coers W., van Straaten J.F.M., Postma D.M. Extracellular matrix and inflammation a role for fibroblast-mediated defective tissue repair in the pathogenesis of emphysema9 // Eur Respir Rev, 1997; 7 (43): 119–23.

81. Tonnesen P. Smoking cessation and prevention // Management of chronic obstructive pulmonary disease/ Eds: Postma D.S., Siafakas N.M. The European Respiratory Society Monograph, 7 May, 1998;127–35.

82. van Herwaarden С., Dekhuyzen P., van Schayck С., et al. Drug treatment of chronic obstructive pulmonary disease // Ned Т Geneesk, 1996; 140 (14): 761–5.

83. Van Noord J.A., Smeets J., Clement J. et al. Assessment of reversibility of airflow obstruction//Amer J Respir Cnt Care Med, 1994; 150 (2): 551–4.

84. Weir Е.К. // Pulmonary hypertension /Eds E.К. Weir, J.Т. Reeves -N.Y., 1984.

85. Weitzenblum M. Demedts Treatment of pulmonary hypertension in chronic obstructive pulmonary disease// Management of chronic obstructive pulmonary disease / Eds: Postma D.S., Siafakas N.M. The European Respiratory Society Monograph, 7 May, 1998; 180–9.

86. Wijkstra P.J., Jones P.W. Quality of life in patients with chronic obstructive pulmonary disease // Management of chronic obstructive pulmonary disease / Eds: Postma D.S., Siafakas N.M. The European Respiratory Society Monograph, 7 May, 1998; 235-47

87. Grossman R. Guidelines for the treatment of acute exacerbations of chronic bronchitis. Chest,1997; 112: 310-3.